Cargando…

Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent

Parasitic infections contribute significantly to worldwide morbidity and mortality. Antibiotic treatment is essential for managing patients infected with these parasites since control is otherwise challenging and there are no vaccines available for prevention. However, new antimicrobial therapies ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirley, Debbie-Ann, Sharma, Ishrya, Warren, Cirle A., Moonah, Shannon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991622/
https://www.ncbi.nlm.nih.gov/pubmed/33777846
http://dx.doi.org/10.3389/fcimb.2021.633194
_version_ 1783669210572914688
author Shirley, Debbie-Ann
Sharma, Ishrya
Warren, Cirle A.
Moonah, Shannon
author_facet Shirley, Debbie-Ann
Sharma, Ishrya
Warren, Cirle A.
Moonah, Shannon
author_sort Shirley, Debbie-Ann
collection PubMed
description Parasitic infections contribute significantly to worldwide morbidity and mortality. Antibiotic treatment is essential for managing patients infected with these parasites since control is otherwise challenging and there are no vaccines available for prevention. However, new antimicrobial therapies are urgently needed as significant problems exist with current treatments such as drug resistance, limited options, poor efficacy, as well as toxicity. This situation is made worse by the challenges of drug discovery and development which is costly especially for non-profitable infectious diseases, time-consuming, and risky with a high failure rate. Drug repurposing which involves finding new use for existing drugs may help to more rapidly identify therapeutic candidates while drastically cutting costs of drug research and development. In this perspective article, we discuss the importance of drug repurposing, review disulfiram pharmacology, and highlight emerging data that supports repurposing disulfiram as an anti-parasitic, exemplified by the major diarrhea-causing parasite Entamoeba histolytica.
format Online
Article
Text
id pubmed-7991622
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79916222021-03-26 Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent Shirley, Debbie-Ann Sharma, Ishrya Warren, Cirle A. Moonah, Shannon Front Cell Infect Microbiol Cellular and Infection Microbiology Parasitic infections contribute significantly to worldwide morbidity and mortality. Antibiotic treatment is essential for managing patients infected with these parasites since control is otherwise challenging and there are no vaccines available for prevention. However, new antimicrobial therapies are urgently needed as significant problems exist with current treatments such as drug resistance, limited options, poor efficacy, as well as toxicity. This situation is made worse by the challenges of drug discovery and development which is costly especially for non-profitable infectious diseases, time-consuming, and risky with a high failure rate. Drug repurposing which involves finding new use for existing drugs may help to more rapidly identify therapeutic candidates while drastically cutting costs of drug research and development. In this perspective article, we discuss the importance of drug repurposing, review disulfiram pharmacology, and highlight emerging data that supports repurposing disulfiram as an anti-parasitic, exemplified by the major diarrhea-causing parasite Entamoeba histolytica. Frontiers Media S.A. 2021-03-11 /pmc/articles/PMC7991622/ /pubmed/33777846 http://dx.doi.org/10.3389/fcimb.2021.633194 Text en Copyright © 2021 Shirley, Sharma, Warren and Moonah http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Shirley, Debbie-Ann
Sharma, Ishrya
Warren, Cirle A.
Moonah, Shannon
Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
title Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
title_full Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
title_fullStr Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
title_full_unstemmed Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
title_short Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
title_sort drug repurposing of the alcohol abuse medication disulfiram as an anti-parasitic agent
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991622/
https://www.ncbi.nlm.nih.gov/pubmed/33777846
http://dx.doi.org/10.3389/fcimb.2021.633194
work_keys_str_mv AT shirleydebbieann drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent
AT sharmaishrya drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent
AT warrencirlea drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent
AT moonahshannon drugrepurposingofthealcoholabusemedicationdisulfiramasanantiparasiticagent